SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/315103"
 

Search: onr:"swepub:oai:gup.ub.gu.se/315103" > Cancer incidence in...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Cancer incidence in healthy Swedish peripheral blood stem cell donors

Pahnke, Simon (author)
Uppsala University,Uppsala universitet,Hematologi,Uppsala Univ, Sweden
Nygell, U. A. (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital,Karolinska Univ Hosp, Sweden; Karolinska Inst, Sweden
Johansson, Jan-Erik, 1963 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology,Sahlgrenska Academy,Univ Gothenburg, Sweden
show more...
Kisch, Annika (author)
Lund University,Lunds universitet,Vård i högteknologisk miljö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Care in high technological environments,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital,Lund Univ, Sweden
Ljungman, P. (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital,Karolinska Univ Hosp Huddinge, Sweden; Huddinge Karolinska Inst, Sweden
Sandstedt, Anna (author)
Linköping University Hospital,Region Östergötland, Hematologiska kliniken US
Hägglund, Hans (author)
Uppsala University,Uppsala universitet,Hematologi,Uppsala Univ, Sweden
Larfors, Gunnar (author)
Uppsala University,Uppsala universitet,Hematologi,Uppsala Univ, Sweden
show less...
 (creator_code:org_t)
2022-03-07
2022
English.
In: Bone Marrow Transplantation. - : Springer Science and Business Media LLC. - 0268-3369 .- 1476-5365. ; 57, s. 795-802
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Granulocyte colony-stimulating factor (G-CSF) has been used for over 20 years to obtain peripheral blood stem cells from healthy donors for allogeneic stem cell transplantation. Concerns have been raised about a potentially increased cancer incidence in donors after donation, especially regarding haematological malignancies. In a prospective Swedish national cohort study, we studied the cancer incidence after donation in 1082 Swedish peripheral blood stem cell donors, donating between 1998 and 2014. The primary objective was to evaluate if the cancer incidence increased for donors treated with G-CSF. With a median follow-up time of 9.8 years, the incidence of haematological malignancies was 0.85 cases per 1000 person-years, and did not significantly differ from the incidence in age-, sex- and residence-matched population controls (hazard ratio 1.70, 95% confidence interval (CI) 0.79-3.64, p value 0.17), bone marrow donors or non-donating siblings. The total cancer incidence for peripheral blood stem cell donors was 6.0 cases per 1000 person-years, equal to the incidence in matched population controls (hazard ratio 1.03, 95% CI 0.78-1.36, p value 0.85), bone marrow donors or non-donating siblings. In this study of healthy peripheral blood stem cell donors, the cancer incidence was not increased after treatment with G-CSF.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Hematologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Hematology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

colony-stimulating factor
long-term safety
g-csf
follow-up
5-year
survivors
unrelated donors
adverse events
increased risk
cd34(+)
cells
leukemia
Biophysics
Oncology
Hematology
Immunology
Transplantation
Medicinsk vetenskap

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view